Eye Care - Indonesia

  • Indonesia
  • In Indonesia, the Eye Care market market generated a revenue of US$105.20m in 2024.
  • It is projected to experience an annual growth rate of 3.99% (CAGR 2024-2029).
  • When compared globally, the in the United States leads in terms of revenue generation, with a total of US$1,256.00m in 2024.
  • Looking at the per person figures, in 2024, the revenue generated per individual stands at US$0.38.
  • With an increasing number of Indonesians seeking affordable and accessible eye care solutions, the OTC eye care market in Indonesia is experiencing significant growth.

Key regions: Australia, Japan, Brazil, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Eye Care market in Indonesia is experiencing significant growth and development. Customer preferences are shifting towards a greater emphasis on eye health and the demand for eye care products and services is increasing. This trend can be attributed to several factors, including a growing awareness of the importance of eye health, an aging population, and the increasing prevalence of eye-related conditions.

Customer preferences:
Customers in Indonesia are becoming more conscious of the importance of maintaining good eye health. They are seeking products and services that can help them prevent and treat eye-related conditions. This includes a wide range of products, such as contact lenses, eyeglasses, and eye drops, as well as services like regular eye check-ups and vision correction procedures.

Trends in the market:
One of the key trends in the Eye Care market in Indonesia is the increasing demand for contact lenses. Contact lenses offer convenience and flexibility compared to traditional eyeglasses, and they are becoming increasingly popular among the younger population. Additionally, advancements in technology have led to the development of more comfortable and breathable contact lenses, further driving their adoption.Another trend in the market is the growing popularity of vision correction procedures, such as LASIK surgery. These procedures offer a permanent solution to vision problems and are gaining traction among those who want to reduce their dependence on eyeglasses or contact lenses. The availability of advanced medical facilities and skilled healthcare professionals in Indonesia has contributed to the growth of this segment.

Local special circumstances:
Indonesia has a large and growing population, which presents a significant market opportunity for eye care products and services. Additionally, the country has a high prevalence of eye-related conditions, such as myopia and cataracts, which further drives the demand for eye care solutions. The government has also taken steps to promote eye health awareness and provide access to affordable eye care services, which has contributed to the growth of the market.

Underlying macroeconomic factors:
The Eye Care market in Indonesia is also influenced by underlying macroeconomic factors. The country's economy has been growing steadily, leading to an increase in disposable income. This has allowed more people to afford eye care products and services, driving the demand in the market. Additionally, advancements in technology and increased competition among market players have resulted in more affordable and accessible eye care solutions.In conclusion, the Eye Care market in Indonesia is experiencing significant growth and development due to shifting customer preferences, including a greater emphasis on eye health. The demand for eye care products and services, such as contact lenses and vision correction procedures, is increasing. Local special circumstances, such as a large and growing population and a high prevalence of eye-related conditions, further contribute to the growth of the market. Underlying macroeconomic factors, including a growing economy and advancements in technology, also play a role in driving the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)